-

Eurofins Opens Europe-Wide COVID-19 Testing Centre Network to Facilitate Summer Travel

LUXEMBOURG--(BUSINESS WIRE)--Easy, reliable, high-quality and cost-effective testing for SARS-CoV-2 (COVID-19), in compliance with local regulatory requirements, is crucial to enabling millions of passengers to complete their journeys in comfort and safety. Eurofins has rapidly developed a broad network of around 500 testing centres across Europe and intends to have established around 1000 testing centres by early July.

Eurofins’ network of testing centres covers major travelling hubs and provides testing accessibility in a broad variety of locations such as supermarkets, business parks and residential areas, improving customer proximity and ease of testing.

Eurofins also operates mobile testing centres to further increase availability and access. Such mobile facilities can be used by municipal authorities to reduce pressure on existing testing centres by quickly adding sampling capacity. These mobile collection centres can each process up to 200 PCR tests per day. Eurofins has already launched this service in Belgium, France and Germany.

Additionally, to further support testing, in particular for European travel this summer, Eurofins has created an intuitive web-portal for travelers to book testing appointments and access their testing information, not only in their country of origin, but also at destination locations. All of Eurofins’ testing centres are listed on a single landing page, identifying nearby testing locations. This portal is available in 12 languages; https://www.eurofins.com/covid19-travel-regulations-testing-stations/

Eurofins is committed to offering the best possible testing services to all travellers looking for a seamless, comfortable and safe travel experience. Eurofins has also invested in laboratory capacity and IT solutions that will ensure fast turn-around times for test results (as low as a few hours from receipt of sample at the laboratory for gold standard PCR Tests). Alongside Eurofins’ home-testing offering (where supported by Health Authorities), the Group’s extensive testing centres and mobile sample facilities enable Eurofins to offer an easy and comprehensive experience for international travellers across Europe and the world.

For more information, please visit https://www.eurofins.com/eurofins-safer-work-covid-19-solutions/.

Notes to editor:

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Javier Sanchez Saura
Investor Relations
Eurofins Scientific SE
E-mail: ir@eurofins.com

Eurofins Scientific SE

BOURSE:ERF

Release Versions

Contacts

Javier Sanchez Saura
Investor Relations
Eurofins Scientific SE
E-mail: ir@eurofins.com

More News From Eurofins Scientific SE

Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 20/07/2026 FR0014000MR3 3 180 70.8332 CEUX EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 20/07/2026 FR0014000MR3 6 820 70.7743 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 21/07/...

Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Financial highlights in H1 2026 Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives. Revenues of €3,701m increased by 2.5% as reported including a 2.9% headwind from foreign currency, and 2.7% organically13. Organic growth13 improved as the half...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Weekly report on share repurchases from 13th July to 17th July 2026   Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07/2026 FR0014000MR3 15 000 69.1984 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/07...
Back to Newsroom